Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 15d PGJ2 cPLA2i 1.0 BCD110605C16 0.118 pmol/ml of medium
- 15d PGJ2 cPLA2i 1.0 BCD110605C18 0.071 pmol/ml of medium
- 15d PGJ2 cPLA2i 1.0 BCD110605C17 0.063 pmol/ml of medium
- 15d PGJ2 cPLA2i 4.0 BCD110605C34 0.033 pmol/ml of medium
- 15d PGJ2 cPLA2i 4.0 BCD110605C36 0.106 pmol/ml of medium
- 15d PGJ2 cPLA2i 4.0 BCD110605C35 0.062 pmol/ml of medium
- 15d PGJ2 cPLA2i 20.0 BCD110605C53 0.086 pmol/ml of medium
- 15d PGJ2 cPLA2i 20.0 BCD110605C54 0.165 pmol/ml of medium
- 15d PGJ2 cPLA2i 20.0 BCD110605C52 0.111 pmol/ml of medium
- 15d PGJ2 PLDi 1.0 BCD110605C10 0.074 pmol/ml of medium
- 15d PGJ2 PLDi 1.0 BCD110605C12 0.105 pmol/ml of medium
- 15d PGJ2 PLDi 1.0 BCD110605C11 0.124 pmol/ml of medium
- 15d PGJ2 PLDi 4.0 BCD110605C30 0.071 pmol/ml of medium
- 15d PGJ2 PLDi 4.0 BCD110605C29 0.068 pmol/ml of medium
- 15d PGJ2 PLDi 4.0 BCD110605C28 0.183 pmol/ml of medium
- 15d PGJ2 PLDi 20.0 BCD110605C48 0.06 pmol/ml of medium
- 15d PGJ2 PLDi 20.0 BCD110605C47 0.1 pmol/ml of medium
- 15d PGJ2 PLDi 20.0 BCD110605C46 0.167 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 1.0 BCD110605C19 0.101 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 1.0 BCD110605C21 0.156 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 1.0 BCD110605C20 0.113 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 4.0 BCD110605C39 0.204 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 4.0 BCD110605C37 0.137 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 4.0 BCD110605C38 0.145 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 20.0 BCD110605C55 0.747 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 20.0 BCD110605C57 0.686 pmol/ml of medium
- 15d PGJ2 KDO+cPLA2i 20.0 BCD110605C56 0.666 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 1.0 BCD110605C15 0.107 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 1.0 BCD110605C14 0.123 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 1.0 BCD110605C13 0.127 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 4.0 BCD110605C32 0.321 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 4.0 BCD110605C31 0.343 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 4.0 BCD110605C33 0.228 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 20.0 BCD110605C49 1.47 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 20.0 BCD110605C51 1.38 pmol/ml of medium
- 15d PGJ2 KDO+PLDi 20.0 BCD110605C50 1.31 pmol/ml of medium
- 15d PGJ2 KDO + ATP 1.0 BCD110605C07 0.108 pmol/ml of medium
- 15d PGJ2 KDO + ATP 1.0 BCD110605C09 0.143 pmol/ml of medium
- 15d PGJ2 KDO + ATP 1.0 BCD110605C08 0.118 pmol/ml of medium
- 15d PGJ2 KDO + ATP 4.0 BCD110605C25 0.299 pmol/ml of medium
- 15d PGJ2 KDO + ATP 4.0 BCD110605C26 0.266 pmol/ml of medium
- 15d PGJ2 KDO + ATP 4.0 BCD110605C27 0.243 pmol/ml of medium
- 15d PGJ2 KDO + ATP 20.0 BCD110605C45 1.66 pmol/ml of medium
- 15d PGJ2 KDO + ATP 20.0 BCD110605C43 1.39 pmol/ml of medium
- 15d PGJ2 KDO + ATP 20.0 BCD110605C44 1.56 pmol/ml of medium
- 15d PGJ2 C 0.0 BCD110605C02 0.125 pmol/ml of medium
- 15d PGJ2 C 0.0 BCD110605C01 0.096 pmol/ml of medium
- 15d PGJ2 C 0.0 BCD110605C03 0.129 pmol/ml of medium
- 15d PGJ2 C 1.0 BCD110605C06 0.097 pmol/ml of medium
- 15d PGJ2 C 1.0 BCD110605C05 0.117 pmol/ml of medium